ALKERMES | Kısa Vadeli Yükümlülükler



Current Liabilities Değişiklik Tarih
AbbVie USD 38.75B 4.31B 2024-12
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
ALKERMES USD 443.73M 21.47M 2025-03
Amgen USD 23.01B 91M 2025-03
Biogen USD 5.3B 231.4M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Gilead Sciences USD 12B 279M 2024-12
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
J&J USD 56.9B 6.58B 2025-03
Malin Corporation EUR 500K 500K 2024-06
Merck USD 28.42B 1.17B 2024-12
Neurocrine Biosciences USD 507.7M 78M 2024-12
Otsuka Holdings JPY 701.72B 69.06B 2025-03
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



ALKERMES Kısa Vadeli Yükümlülükler - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - May 2025.